Vivo Capital Fund IX, L.P.

Vivo Capital Fund IX, L.P. is 10% Owner at Tarsus Pharmaceuticals, Inc. (TARS). They have made 2 open-market trades across 1 company since 2020, most recently 2022-05-04.

CIK 0001750117

Get an email the next time Vivo Capital Fund IX, L.P. files.Follow for free

1 open-market purchase totalling $4.0M since 2020, against 1 sale. Too few scored purchases to measure a record yet.

Also files as

Controlled by Jack Nielsen

Jack Nielsen Vivo Capital Fund IX, L.P. (entity)

Current Position

Ticker	Shares	Value
TARS	2,494,113	$169.8M
TIL	11,709,696	$69.8M
IOBT	2,365,545	$118K
Total		$239.8M

Shares reported on the most recent Form 4, priced at the 2022-05-04 close.

Grade by Ticker

Get an email the next time Vivo Capital Fund IX, L.P. files

Free account. One email when the next filing comes in.

Follow Vivo Capital Fund IX, L.P. for free

Buy Track Record

Filings1

Only 1 discretionary filing — too few to score

Discretionary filings only. 10b5-1 plan trades, tax withholding and option exercises are excluded, and each column is one row per filing rather than per execution lot.

Sell Track Record

Filings1

Only 1 decision-sell filing — too few to score

Decision sells only — a first sale after buying the stock, or a sale by a fund or 10% owner. Ordinary sales by officers and directors show no relationship to what the stock does next, so they are counted but not scored.